Thomas Witzig

Thomas Witzig

Mayo Clinic - Rochester / United States
Others
AD Scientific Index ID: 1352335
Mayo Clinic College of Medicine and Science
person_outline Thomas Witzig's MOST POPULAR ARTICLES
1-) Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphomaSS Neelapu, FL Locke, NL Bartlett, LJ Lekakis, DB Miklos, CA Jacobson, ...New England Journal of Medicine 377 (26), 2531-2544, 201734432017
2-) Review of 1027 patients with newly diagnosed multiple myelomaRA Kyle, MA Gertz, TE Witzig, JA Lust, MQ Lacy, A Dispenzieri, ...Mayo Clinic Proceedings 78 (1), 21-33, 200328112003
3-) Effective surgical adjuvant therapy for high-risk rectal carcinomaJE Krook, CG Moertel, LL Gunderson, HS Wieand, RT Collins, RW Beart, ...New England Journal of Medicine 324 (11), 709-715, 199122851991
4-) Targeting apoptosis pathways in cancer therapyIM Ghobrial, TE Witzig, AA AdjeiCA: a cancer journal for clinicians 55 (3), 178-194, 200518972005
5-) Randomized controlled trial of yttrium-90–labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade …TE Witzig, LI Gordon, F Cabanillas, MS Czuczman, C Emmanouilides, ...Journal of clinical oncology 20 (10), 2453-2463, 200215962002